Lantern Pharma is trading at $2.70 (+9.56%) today as part of a broader risk-on move in U.S. equities.
- The Nasdaq Composite is up 2.45% as technology stocks rally following strong Microsoft earnings and cooling inflation data.
- While there are no clear company-specific announcements, the stock is benefiting from the supportive macroeconomic backdrop and sector-wide gains.